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ABSTRACT White lupin (Lupinus albus, L.), a widely cultivated crop that has been consumed for many years in
Western Europe, may provide a useful alternative for individuals wishing to substitute animal with plant proteins for
cardiovascular disease prevention. Lupin seeds have a very low content of isoflavones, and lupin protein isolates
are essentially isoflavone free. In rats fed a casein-based cholesterol  cholic acid diet, a relatively low daily intake
(50 mg/d by gavage for 2 wk) of total lupin protein extract reduced plasma total and VLDL  LDL cholesterol
concentrations by 21 and 30%, respectively (both P  0.001). In an attempt to elucidate the lipid-lowering
mechanism, LDL receptor activity was evaluated in a human hepatoma cell line (HepG2). In this model, the lupin
total protein extract was essentially inactive, whereas one purified minor protein component, conglutin , had a
remarkable upregulatory effect, with maximal increases of 53 and 21% (both P  0.05) for LDL uptake and
degradation, respectively. This initial study indicates that lupin, although isoflavone free, has hypocholesterolemic
activity similar to that of other leguminous proteins in an established animal model. Further, the cholesterol
reduction appears to be associated with stimulation of LDL receptors by a well-defined protein component of the
lupin seeds as demonstrated by in vitro studies. J. Nutr. 134: 18–23, 2004.
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Plant proteins in the diet have been shown to successfully
reduce cholesterolemia in experimental animals and humans
(1–3). The cholesterol-reducing effect, potentially leading to
reduced cardiovascular risk, was the basis for the U.S. FDA
approval of the health claim concerning the role of soybean
proteins in reducing the risk of coronary disease (4).
Approval of the claim and the wide availability of numer-
ous products derived from soybeans, has definitely led to a
greater use of these food items. This has not been the case in
Western Europe, however, where soy protein–based foods are
still used to a modest extent (5), partly because these products
are foreign to European food culture and partly because of
public concern about the use of genetically modified foods (6).
In addition, doubts still exist concerning the mechanism(s)
whereby soy protein–based foods may reduce cholesterolemia
and cardiovascular risk. The claim that the isoflavones of soy,
particularly daidzein and genistein, may affect cholesterolemia,
was strongly supported by a major meta-analysis on the cho-
lesterol-lowering effect of soybeans (3). This hypothesis is
supported in part by experimental and clinical studies with hot
ethanol-extracted isoflavone-free soybean products, apparently
with reduced cholesterol-lowering potential (7,8). On the
other hand, readdition of the ethanol-extracted material to
the diet did not cause any relevant cholesterol reduction (9).
A recent proteomic investigation by our group (10) showed
that the extraction of isoflavones with ethanol changes the
protein/peptide profile of the protein isolates with unpredict-
able effects on activity. In a study in which removal of the
isoflavones from soy protein isolates was achieved by a chro-
matographic procedure (11), the milder purification did not
alter their hypocholesterolemic properties. Further, both cho-
lesterolemia and atherosclerosis appeared to be positively cor-
related with plasma isoflavone concentrations in primates fol-
lowing a soybean-containing diet (12); a very recent study also
reported a direct correlation between plasma isoflavones and
cholesterolemia in hamsters (13). Finally, the major clinical
studies in type II hypercholesterolemic patients were con-
ducted with isoflavone-poor soybean products (14), and in
vitro studies have clearly indicated that specific protein frac-
tions of soybean, in particular the  subunit of the 7S globulin
and peptides thereof, can directly activate LDL receptors in
liver cells (15,16).
Because potentially harmful effects of isoflavones have been
reported in recent years (17), we decided to investigate alter-
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native legume protein products with a low isoflavone content;
such products might be more acceptable to European consum-
ers as an alternative to soybeans. The only other protein-rich
grain legume is lupin (18), a common name that represents
four domestic species, Lupinus albus (white lupin), L. luteus
(yellow lupin), L. mutabilis (blue lupin) and L. angustifolius
(narrow-leaf lupin). At present, the most important lupin-
producing country worldwide is Australia, whereas in Europe,
lupin is cultivated mostly in France, Poland, Russia, Hungary
and Italy (19).
The alkaloids that confer a bitter taste to lupin kernels in
modern varieties (sweet lupin) have been reduced to very low
levels through conventional breeding techniques (20). In ad-
dition, an interesting feature of lupin is the very low (or nil)
content of antinutritional factors, such as phytate, tannins,
lectins, protease inhibitors and indigestible oligosaccharides
(21–23).
Lupin seeds contain two classes of proteins which, accord-
ing to Osborne’s classification (24), belong to the albumin and
globulin fractions, in the quantitative ratio of 1:9. In turn,
the globulins consist of the two classical major storage pro-
teins, i.e., the 7S and 11S globulins, called conglutins  and ,
respectively, in lupin and two minor distinct protein types,
conglutins  and  (25). Conglutin  is an oligomeric lupin
seed glycoprotein comprising 5% of the total lupin proteins
(26). All of these proteins have been characterized at the
molecular level, although only conglutin  has a known amino
acid sequence (27). Although lupin proteins have been thor-
oughly investigated for their potential food and feed applica-
tions for a long time, lupin’s reputation as a minor crop and
the lack, especially in Europe, of suitable industrial processing
practices have prevented the wide diffusion of these proteins as
important food components in the processed food chain.
Preliminary studies with seed meals and lupin fractions
showed a substantial reduction of cholesterolemia in male rats
(28); however, the chemical composition of the products used
in that study and in a more recent one were not described fully
(29). Because there is indication that lupin seeds may contain
very low levels of isoflavones (30), the present study had the
following objectives: 1) to confirm the very low content of
isoflavones in seeds of white lupin, the predominant species in
Europe; 2) to evaluate the cholesterol-lowering potential of
lupin protein products in an established rodent model of
hypercholesterolemia; and 3) to investigate whether isolated
lupin protein fractions exert an LDL receptor upregulatory
activity in a human liver cell line.
MATERIALS AND METHODS
Lupin samples. White lupin seeds (Lupinus albus L.) were of the
sweet Multitalia variety and were kindly provided by Dr. M. Fagnano,
University of Naples, Italy.
Lupin protein preparation. The total protein extract (TPE)3
from lupin seed was prepared as described below. Lupin seeds were
manually dehusked and the kernels ground with a domestic coffee
grinder. The flour was defatted in boiling hexane in a Soxhlet
apparatus for 4 h. The defatted flour was then passed through a
60-mesh metal sieve. The resulting flour was then extracted in MilliQ
water (Millipore, Billerica, MA), adjusted to pH 8.5–9.0 with diluted
NaOH in a ratio of 1:20 (wt/v) with stirring at 5°C for 3 h. The pH
was monitored regularly and readjusted to the original pH with
diluted NaOH. Based on the solubility properties of lupin proteins,
this step allowed their effective extraction. The slurry was then
filtered on Miracloth (Calbiochem Corp., La Jolla, CA) tissue and
centrifuged at 10,000  g for 30 min at 20°C. The supernatant,
consisting of the proteins, was treated with 90% ammonium sulfate at
4°C and the protein pellet was recovered by centrifugation as above.
The pellet was then resuspended in MilliQ water and thoroughly
dialyzed at 4°C for 24 h with frequent changes of water. The protein
suspension was recovered and freeze-dried. The dried powder con-
sisted of the lupin TPE with a protein content  95 g/100 g (not
shown).
Purification of lupin conglutin. Conglutin  (C) was purified
essentially as described by Duranti et al. (31) by using a combination
of anion and cation exchange chromatography. Purified C was
precipitated with ammonium sulfate (80% saturation) and then
treated as the TPE. Homogeneity of the purified C was verified by
SDS-PAGE (not shown).
Identification and quantitative analysis of lupin isoflavones. Be-
cause these isoflavones are not synthesized in dry lupin seeds but only
during germination (30), we grew some lupin plants for 3 mo, and
extracted and analyzed the isoflavones from the leaves by LC-MS/MS
to have a correct identification of all of the peaks in lupin seeds (32).
The extraction of isoflavones was performed as indicated for soybeans
by Wang and Murphy (33). Each sample (1 g) was stirred for 2 h in
a mixture of 5 mL acetonitrile, 2.5 mL distilled water and 1 mL 0.1
mol/L HCl. After filtration, the solvent was dried under a vacuum,
and the residue was dissolved in 1 mL of 50% methanol and filtered
on 0.45-m filters. Analyses were performed on a microbore column,
Alltima C18 (Alltech, Deerfield, IL), 3 m, 150 2.1 mm under the
following conditions: eluent A, 0.1% acetic acid in acetonitrile;
eluent B, 0.1% acetic acid in water; gradient 15% A to 35% A in 50
min, then 35% A for 10 min; flow 0.2 mL/min; temperature 30°C.
The isoflavone identification was completed by LC-electrospray ion-
ization-MS/MS on an Agilent SL 100 Series LC/mass selective de-
tector trap (Agilent, Palo Alto, CA) equipped with an Agilent 1100
binary pump and an Agilent 1100 Diode Array Detector (DAD)
under the following conditions: source temperature 325°C; nebulizer
18 psi; drying gas 6 L/min; capillary voltage 4000 V; scan range
60–700 m/z. Analyses were performed in negative ion mode because
the sensitivity is higher than in positive ion mode.
Quantitative analyses were carried out on flour from lupin seeds,
TPE and C. The extraction was performed as indicated for the
leaves. The quantification was done with both diode array detection
at 254 nm and MS with the external standard method. Isoflavone
determinations had CV ranging between 2 and 10%. Isoflavone
standards were kindly provided by Indena SpA Milano, Italy.
In vivo studies
Animals, diets and experimental protocol. Male Sprague-Daw-
ley rats (Charles River Italia, Calco, Italy; body weight 200–225 g)
were housed in a room with controlled lighting (12 h/d), constant
temperature (18°C) and relative humidity (55–65%). During wk 1,
they were fed a pelleted commercial nonpurified diet (Piccioni, Ges-
sate, Italy) and then were divided into two groups of 10 rats on the
basis of body weight, plasma lipids and glycemia so that the distribu-
tion among the groups was similar. The rats were then transferred to
a Nath’s hypercholesterolemic diet (1 g/100 g cholesterol and 0.5
g/100 g cholic acid) (34). Feed and water were freely available.
TPE from lupin was given daily by gavage at 0900 h at a dose of
50 mg/rat, dissolved in water with a small amount of carboxymeth-
ylcellulose for 2 wk; control rats were administered vehicle only. The
Institutional guides for the care and use of laboratory animals were
followed, and the experiments were supervised by the Laboratory
Animal Welfare Service.
Plasma cholesterol, triglyceride and glucose levels were deter-
mined by enzymatic methods (Boehringer SA, Mannheim, Ger-
many); plasma lipoproteins were separated by ultracentrifugation
using pools from two rats (35) by appropriate density cuts.
In vitro studies
Cell culture. The established human hepatoma cell line
(HepG2) was obtained from American Type Culture Collection
3 Abbreviations used: C, conglutin ; FCS, fetal calf serum; HC, hypercho-
lesterolemic; LDH, lactate dehydrogenase; LPDS, lipoprotein-deficient serum;
MTT, methyltetrazolium salts; TPE, total protein extract.
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(Rockville, MD). Eagle’s MEM, fetal calf serum (FCS), trypsin-
EDTA (1X), penicillin (105 U/L), streptomycin (100 g/L), tricine
buffer (1 mmol/L, pH 7.4) and nonessential amino acid solutions
(100X) were from GIBCO (Madison, WI). Protease inhibitor cock-
tail for use with mammalian cell and tissue extracts was from Sigma-
Aldrich (Milano-Italy). Petri dishes were from COSTAR (Cam-
bridge, MA). Filters were from Millipore (Bedford, MA). The Protein
Coomassie Plus Protein Assay kit was purchased from Pierce (Rock-
ford, IL). 125Iodine, carrier free, in 100 mmol/L NaOH, was from
Perkin Elmer Life Sciences (Boston, MA). Sephadex G25 columns
(PD10) were from Pharmacia Biotech (Uppsala, Sweden). All other
chemicals were of analytical grade and were from Merck (Darmstadt,
Germany).
Cells were grown in monolayers in 90-mm diameter Petri dishes,
and maintained at 37°C in a humidified atmosphere of 95% air, 5%
CO2 in MEM supplemented with 10% FCS, non essential amino acid
solution (1%, v/v), penicillin (105 U/L), streptomycin (0.1 g/L),
tricine buffer (20 mmol/L, pH 7.4), NaHCO3 (24 mmol/L) and
sodium pyruvate (0.11 g/L). For experiments designed to evaluate the
LDL receptor modulation, cells were seeded in 35-mm plastic dishes
(3–5  105 cells) and used just before reaching confluence. In all cell
culture experiments, the medium was changed every 2–3 d.
To assess cell viability, culture media from cells exposed to the
different lupin preparations (all for TPE and the highest for C) were
tested by methyltetrazolium salts (MTT) assay, essentially as de-
scribed by Lovati et al. (15). Cell enzyme leakage was determined by
measuring lactate dehydrogenase (LDH) activity, using a kinetic
(LDH/LD) diagnostic kit (Sigma Diagnostics).
Lipoproteins and lipoprotein-deficient serum. LDL (1.019  d
 1.063 kg/L) were isolated by sequential preparative ultracentrifu-
gation (35) from the plasma of clinically healthy normolipidemic
volunteers. Lipoproteins were labeled according to the method of
McFarlane as modified by Bilheimer et al. (36), as previously de-
scribed (15). 125I-LDL were sterilized by filtration (Millipore filters,
0.45-m pore size) and stored at 4°C until use (10 d after prepa-
ration). Human lipoprotein-deficient serum (LPDS) was prepared
using the method of Goldstein et al. (37).
Uptake and degradation of 125I-LDL. Monolayers of cells were
preincubated for 24 h at 37°C in MEM supplemented with 5 g/100 g
LPDS to upregulate the LDL receptors (37), in the presence or
absence of TPE or C at different concentrations. A fixed concen-
tration (7.5 mg/L) of 125I-LDL was then added to the medium and the
incubation continued for a further 4 h at 37°C. Specific uptake
(binding  internalization) and degradation of 125I-LDL were eval-
uated as previously reported (15).
Statistical analyses. Statistical analyses of the individual differ-
ences in plasma lipids and lipoproteins were carried out with Stu-
dent’s t test. Differences in cell uptake and degradation of LDL after
incubation with the different proteins were determined by ANOVA
(SYSTAT 5.2, running on an Apple Macintosh LC 630) followed by
Dunnett’s test. Values are generally expressed as means  SEM;
P-values  0.05 were considered to be significant.
RESULTS
Isoflavone identification and quantification. There are
clear differences in the isoflavone pattern between white lupin
(30) and soybeans (33). In lupin, genistein is present as genis-
tin (7-O-glycoside) and malonylgenistin (6-O-malonyl-7-O-
glycoside) as in soybean, but also as the 4-O-glycoside (Fig.
1). Daidzein and glycitein are not biosynthesized and are
replaced by 2-hydroxygenistein and 2-hydroxygenistin (the
7-O-glycoside). Six isoflavones were identified in lupin leaves
(Table 1); their relative retention times compared with
genistein and the main ions of their mass spectra are reported.
At the end of this experiment, flour from dry seeds, TPE
and purified C underwent isoflavone quantification. In the
seeds, only negligible amounts of genistin and genistein were
present, whereas in TPE and C, the isoflavones were all
below the detection limits of our method (0.1 nmol/g)
(Table 2).
The present study clearly shows the lack of any relevant
presence of isoflavones in lupin seeds compared with soybeans,
for which concentrations of 1500–2000 g/g dry weight are
generally reported (33). Moreover the procedures required for
the purification of TPE and C completely removed these
antinutrients.
In vivo evaluation. HC (hypercholesterolemic) rats had
lower plasma total (	21%) and VLDL-LDL cholesterol con-
centrations (	30%), and lower triglyceride levels (	17%)
after administration of 50 mg/d lupin TPE (Table 3); HDL
cholesterol levels tended to be 20% higher in lupin-treated
rats at the end of the study (P  0.10). Plasma glucose did not
differ between the groups. The rats did not experience any side
effects from treatment; body weight gain in rats fed lupin
tended to be greater than that of controls (P  0.10).
In vitro assays on HepG2 cells. For Hep G2 cells that
were grown in the presence of LPDS to have maximal LDL
receptor activation,we exposed them to both lupin TPE and
isolated C, at concentrations shown in previous studies with
soy globulins from our group (12,13) to adequately upregulate
LDL receptor activity. Although TPE appeared to be totally
ineffective in this model system, C, at the two maximal
concentrations tested, stimulated LDL receptor–mediated up-
take and degradation by 53 and 21%, respectively (Table
4). At no concentration of either TPE or C was there any
evidence of cellular toxicity, as determined by the MTT and
LDH assays.
DISCUSSION
The growing interest in diets rich in vegetable proteins has
prompted a number of investigations on the potential value of
FIGURE 1 Chemical structures of the isoflavones found in the
leaves of 3-mo-old white lupin plants.
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such dietary alternatives for a variety of conditions, ranging
from hypercholesterolemia and atherosclerosis (4), to prostate
and breast cancer prevention (38,39), to cognitive function
(40), to osteoporosis prevention (41) and to menopausal
symptom treatment (42). These studies have often provided
inconsistent results, mainly because of the difficulty in singling
out the relative benefits of the proteins in soybean from other
components responsible for the therapeutic effect. In particu-
lar, the value of the isoflavone/phytoestrogen content of soy-
beans, considered by a large number of investigators as the key
factor in the potential benefits of soybeans in menopause, for
example (42), has been disputed by generally equivocal results
(43,44). A number of very recent reports from a working group
of the UK Committee on Toxicity of Chemicals in Food
(COT) expressed general skepticism concerning the health
benefits of soy isoflavones, in particular for cholesterol reduc-
tion (45).
The role of isoflavones in the mechanism of cholesterol
reduction exerted by soy products was scrutinized in particular
because most studies on hypercholesterolemic individuals, dis-
playing the most marked cholesterol reductions, were con-
ducted with isoflavone-free products (3,14). In addition, very
recent clinical studies in subjects with moderate cholesterol
elevations (probably not very responsive to soy intake), indi-
cated that isoflavone-depleted soy products reduced cholester-
olemia just as well as intact products (46). More interestingly,
administration of soy foods with highly variable isoflavone
contents to hypercholesterolemic patients resulted in essen-
tially identical cholesterol reductions (47). In the present
study, the presence of isoflavones in lupin proteins was clearly
ruled out; data on the lupin protein effects can be analyzed per
se because other components that might influence lipid me-
tabolism were not present.
Evaluation of the cholesterol-lowering effect of lupin pro-
teins was carried out with a total protein extract (TPE) due to
the lack of availability of adequate amounts of purified frac-
tions for animal studies. In this established animal model with
consumption of a casein diet with cholesterol and cholic acid
(34), a daily dose of 50 mg TPE/rat, equivalent to 250 mg/kg,
a frequently used dosage for lipid-lowering medications, e.g., of
the fibrate class (48), reduced total plasma and VLDL-LDL
cholesterol, with a somewhat lesser effect on triglycerides over
2 wk, and tended to increase HDL cholesterol. The rats had a
normal body growth over the treatment period.
In an effort to investigate the mechanism of the reduction
of cholesterolemia, we evaluated the effect of TPE and isolated
components on LDL receptor activity in a human hepatoma
cell line (Hep G2), using an approach similar to that used in
previous studies by our group on soy proteins (15,16). Inter-
estingly, there was no direct effect of the TPE on LDL receptor
activity, whereas there was clear evidence of upregulatory
activity by the C component (31). Although we showed by
2D-electrophoretic mapping (not shown) that the TPE used in
the cell assay did contain C, the amount contained in the
TPE maximal dosage was below the effective dose of purified
C. These findings will thus require further confirmation, but
indicate an area in which to investigate protein components
that more directly affect cholesterolemia, i.e., similar to what
we reported previously in the case of the  globulin from
soy (16).
The present findings should, of course, be viewed with
caution because the lack of major lupin globulin amino acid
sequences prevented direct comparison with the soybean 7S
globulin, although sequence homologies between the 7S glob-
ulins of lupin and soybean seeds can be expected on the basis
TABLE 3
Body weights and plasma lipid and glucose concentrations in
rats fed diets containing cholesterol and cholic acid and orally
administered vehicle or 50 mg total lupin protein extract (TPE)
daily for 2 wk1,2
Vehicle TPE
mmol/L
Total cholesterol 5.48  0.17 4.34  0.20*
VLDL  LDL cholesterol 4.90  0.24 3.42  0.17*
HDL cholesterol 0.70  0.04 0.91  0.03
Triglycerides 0.83  0.06 0.70  0.03**
Glucose 5.33  0.24 5.33  0.37
Body weight, g
Initial 232.5  12.6 216.6  8.4
Final 305.7  7.1 298.2  10.0
1 Values are means  SEM, n 
 10 pools of 2 rats each. * P  0.001;
** P  0.01 vs. vehicle.
TABLE 1
Identification and quantification of isoflavonoids in leaves of white lupin plants1
Isoflavone
Relative
retention time Negative ions in mass spectra (base peak in bold)
Dry leaves,
g/g
2-Hydroxygenistin (5) 0.478 895 [dimer-H]; 507 [M-H  AcOH]; 447 [M-H]; 285 [M-H-Gluc] 577  62
2-Hydroxygenistein (2) 0.870 571 [dimer-H]; 285 [M-H]; 244  14
6-O-Malonylgenistin (4) 0.751 1035 [dimer-H]; 517 [M-H]; 473 [M-H-CO2]; 269 [M-H-MalGluc] 540  78
Genistin (3) 0.619 863 [dimer-H]; 491 [M-H  AcOH]; 431 [M-H]; 269 [M-H-Gluc] 870  108
Genistein-4-glucoside (6) 0.698 863 [dimer-H], 491 [M-H  AcOH]; 431 [M-H] 1373  159
Genistein (1) 1.000 539 [dimer-H]; 269 [M-H] 207  35
1 Concentrations are means  SEM, n 
 3.
TABLE 2
Isoflavonoid concentrations in seeds of Lupinus albus1,2
Isoflavonoid Dry seeds, nmol/g Dry seeds, g/g
Genistin 8.70  1.36 3.76  0.59
Genistein 6.83  0.39 1.84  0.1
Total 15.53 5.60
1 Values are means  SEM, n 
 3.
2 Genistin and genistein were undetectable (0.1 nmol/g) in TPE
and conglutin .
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of the general homology in this class of legume proteins (49).
Nevertheless, important differences, such as the endogenous
extensive proteolytic cleavage of lupin 7S globulin, which
gives rise to a number of noncovalently linked polypeptide
fragments in the native protein conformation, have been
described (50). The cloning and sequencing of 7S and 11S
lupin globulin cDNAs are currently in progress in our labora-
tory. No homology between the C amino acid sequence and
the soybean 7S globulin has been found. Thus, the biological
activity described in this paper might have a different molec-
ular basis than that of soybean globulin. However, more de-
tailed investigations on the various molecular properties of the
lupin proteins in relation to cholesterol metabolism are re-
quired. Finally, the lack of adequate amounts of lupin proteins
did not allow the evaluation of the effect of a total substitution
in the rats’ diet, in term of both lipids and other nutritional
aspects.
This report clearly indicates that protein from a naturally
isoflavone-poor legume can effectively reduce cholesterolemia
and, most likely, upregulate LDL receptor activity, a widely
accepted mechanism of cholesterol reduction associated with
the intake of vegetable proteins (51). The growing interest in
this product and its widespread availability clearly suggest its
potential therapeutic use in hypercholesterolemia, particularly
in individuals in whom soy treatment has significantly reduced
cholesterol concentrations, probably associated with reduced
cardiovascular risk.
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